Tapezza is a prescription medication used to treat a rare eye disease called thyroid eye disease. The drug has been linked to several serious side effects, including hearing loss. As a result, several lawsuits have been filed against the drug’s manufacturer, alleging that the company failed to adequately warn patients and doctors about the potential risks associated with the medication.
This article will examine the Tapezza hearing loss lawsuit in detail, exploring the causes of the controversy, the current status of the litigation, and what patients who have taken the drug need to know.
What is Tapezza?
Healthline states that in case you suffer from thyroid eye disease (TED), your physician might suggest Tepezza as a treatment option to alleviate your symptoms. Tepezza is a prescribed drug meant for adults diagnosed with TED, a condition where the immune system attacks the fat and muscle tissues behind the eyes, leading to symptoms such as eye pain, redness, double vision, and bulging eyes.
Tapezza is administered through injections into the affected eye, typically over several months. While the medication has been effective in treating the symptoms of thyroid eye disease in some patients, it has also been linked to several serious side effects, including hearing loss.
The Link to Hearing Loss
The Tapezza lawsuit alleges that the medication used to treat thyroid eye disease can cause hearing loss as a side effect. According to the plaintiffs, Tapezza contains a chemical compound known as tocilizumab, which has been linked to hearing loss in some patients.
This compound works by suppressing the immune system, which can help reduce inflammation in the eyes. However, it is also believed to be capable of attacking and damaging the sensory hair cells in the inner ear, leading to hearing loss.
The plaintiffs claim that they were not properly warned of this potential side effect by the drug’s manufacturer and are seeking compensation for the harm they have suffered.
TorHoerman Law states that numerous lawsuits regarding Tepezza have been filed in state courts nationwide. Additionally, the law firm reported that recent development in the case involves the consolidation of hearing loss lawsuits.
Specifically, a motion has been filed in the U.S. District Court for the Northern District of Illinois to combine the cases of ten individuals who have experienced hearing loss as a result of using Tepezza to have them heard before a single judge.
The Science Behind the Claim
Drugwatch notes that according to a study involving 26 participants who received four or more infusions of Tepezza, 23% experienced hearing loss. The authors of the study reported that the hearing loss was either newly developed or worsened after taking the medication. Although some patients experienced relief from the symptoms after a few months of discontinuing the drug, others continued to experience the symptoms even after stopping the treatment.
While this study is small, it raises concerns about the potential risks of Tapezza.
Who is Affected
AboutLawsuits.com notes that Tepezza, initially designed for a limited market, saw a doubling of sales to $1.66 billion during its second year in the U.S. market. However, critics were worried that Tepezza was aggressively promoted without proper disclosure of its potential risks. Numerous former users are now claiming that they suffered from hearing damage due to Tepezza, with several symptoms persisting even after discontinuing the medication.
Individuals who have taken Tapezza for the treatment of thyroid eye disease and have experienced hearing loss may be affected by this issue. Additionally, family members of those who have experienced hearing loss as a result of taking Tapezza may also be impacted.
It is important to note that not all individuals who have taken Tapezza will experience hearing loss, and the extent of the hearing loss may vary. However, those affected may be facing significant challenges related to their hearing loss, such as difficulty communicating, social isolation, and decreased quality of life.
Implications for the Medical Community
The Tapezza lawsuit has important implications for the medical community, as it highlights the importance of being aware of the potential side effects of medications. If the plaintiffs are successful in the lawsuit, it may result in changes to prescribing practices for Tapezza and other similar medications.
Additionally, medical professionals may become more aware of the potential for hearing loss as a side effect of certain medications and may take extra precautions to monitor their patients’ hearing health.
The outcome of the lawsuit could also lead to increased scrutiny of pharmaceutical companies and their duty to provide accurate information about the potential risks and side effects of their products.
In conclusion, the Tapezza hearing loss lawsuit has brought attention to the medication’s potentially serious side effects. While Tapezza is a commonly prescribed treatment for thyroid eye disease, it has been alleged that it can cause hearing loss in some patients.
The scientific evidence supporting this claim is being examined in the ongoing lawsuit against the manufacturer. If the plaintiffs are successful, they may be awarded damages for their medical expenses, lost wages, and pain and suffering. The lawsuit may also have implications for the medical community, leading to changes in prescribing practices and increased awareness of potential side effects.
It is important for patients to be informed about the risks and benefits of any medication they take and to discuss any concerns with their healthcare provider.